Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have announced a new multi-year partnership to conduct collaborative research to rapidly advance therapies for various types of cancers, including gastrointestinal and lung cancers.
The establishment of a joint Virtual Research and Development Center will enable effective data sharing and analysis between the two organizations. more